| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $2.17 (Beat by $0.35) |
| EPS GAAP Actual | $2.17 (Beat by $0.35) |
| Revenue Actual | $0.251153B |
| Revenue Surprise | Beat by $251.153M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.33 |
| EPS GAAP Estimate | $1.33 |
| Revenue Estimate | $0.2233B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2029 | 0 | INF | 0 | 0 | 0 |
| Jan 2029 | 11.26 | 36.41 | 11.04458 | 11.56276 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.22 | 1.07 | 0.251153B | -2.33% | 68.95M |
| FQ3 2025 (Jul 2025) | 2.57 | 1.56 | 0.237743B | 4.51% | 68.74M |
| FQ2 2025 (Apr 2025) | 1.65 | 1.65 | 0.19366B | 18.58% | 193.66M |
| FQ1 2025 (Jan 2025) | 2.31 | 2.31 | 0.232474B | 29.22% | 232.47M |
| FQ4 2024 (Oct 2024) | 2.07 | 2.07 | 0.257008B | 36.28% | 257.01M |
| FQ3 2024 (Jul 2024) | 1.36 | 1.36 | 0.227015B | 37.74% | 227.02M |
| FQ2 2024 (Apr 2024) | 0.59 | 0.59 | 0.157682B | 34.25% | 157.68M |
| FQ1 2024 (Jan 2024) | 0.9 | 0.9 | 0.164554B | 27.82% | 164.55M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
1.33
Consensus Revenue Estimates
0.2233B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 2.52 | -- | 2.51358 | 2.52642 | 1 |
| FQ4 2027 (Oct 2027) | 2.52 | -- | 2.51358 | 2.52642 | 1 |
| FQ3 2027 (Jul 2027) | 2.49 | -- | 2.48365 | 2.49635 | 1 |
| FQ2 2027 (Apr 2027) | 2.33 | -- | 2.32406 | 2.33594 | 1 |
| FQ1 2027 (Jan 2027) | 1.51 | -- | 1.48833 | 1.53167 | 0 |
| FQ4 2026 (Oct 2026) | 1.46 | -52.05 | 1.43905 | 1.48095 | 0 |
| FQ3 2026 (Jul 2026) | 1.44 | -78.47 | 1.41933 | 1.46067 | 0 |
| FQ2 2026 (Apr 2026) | 1.34 | -23.13 | 1.32077 | 1.35923 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 0.32B | -- | 0.31B | 0.32B | 1 |
| FQ4 2027 (Oct 2027) | 0.31B | -- | 0.31B | 0.31B | 1 |
| FQ3 2027 (Jul 2027) | 0.31B | -- | 0.31B | 0.31B | 1 |
| FQ2 2027 (Apr 2027) | 0.29B | -- | 0.29B | 0.29B | 1 |
| FQ1 2027 (Jan 2027) | 0.25B | -- | 0.25B | 0.25B | 1 |
| FQ4 2026 (Oct 2026) | 0.24B | -3.02 | 0.24B | 0.25B | 1 |
| FQ3 2026 (Jul 2026) | 0.24B | 1.27 | 0.24B | 0.24B | 1 |
| FQ2 2026 (Apr 2026) | 0.23B | 15.54 | 0.23B | 0.23B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 1.15 | 2.22 | 1.07 | 48.2% |
| FQ3 2025 (Jul 2025) | 1.01 | 2.57 | 1.56 | 60.7% |
| FQ2 2025 (Apr 2025) | 1.65 | 1.65 | 100% | |
| FQ1 2025 (Jan 2025) | 2.31 | 2.31 | 100% | |
| FQ4 2024 (Oct 2024) | 2.07 | 2.07 | 100% | |
| FQ3 2024 (Jul 2024) | 1.36 | 1.36 | 100% | |
| FQ2 2024 (Apr 2024) | 0.59 | 0.59 | 100% | |
| FQ1 2024 (Jan 2024) | 0.9 | 0.9 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0.18B | $0.25B | $68.95M | 27.45% |
| FQ3 2025 (Jul 2025) | $0.17B | $0.24B | $68.74M | 28.91% |
| FQ2 2025 (Apr 2025) | $0B | $0.19B | $193.66M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.23B | $232.47M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.26B | $257.01M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.23B | $227.02M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.16B | $157.68M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.16B | $164.55M | 100% |